从英国初级保健数据中确定COPD专科干预的资格:一种“可治疗的特征”方法。

IF 3.1 3区 医学 Q2 RESPIRATORY SYSTEM
Thomas J C Ward, Catherine John, Alexander T Williams, Chiara Batini, Neil J Greening, Martin D Tobin, Michael C Steiner
{"title":"从英国初级保健数据中确定COPD专科干预的资格:一种“可治疗的特征”方法。","authors":"Thomas J C Ward, Catherine John, Alexander T Williams, Chiara Batini, Neil J Greening, Martin D Tobin, Michael C Steiner","doi":"10.2147/COPD.S502865","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Specialist intervention in COPD is often reactive, resulting in inequalities in the provision of care. A proactive approach, in which individuals with modifiable disease are identified from primary care records, may help to tackle this inequality in access.</p><p><strong>Aim: </strong>To estimate the prevalence of \"treatable traits\" in COPD in a primary care research database and to assess health service usage.</p><p><strong>Methods: </strong>We performed a secondary analysis of individuals with either 1) a primary care diagnosis of COPD or 2) obstructive spirometry and history of ever smoking in a large observational study recruiting individuals aged 40-69 years old in Leicestershire, UK. Spirometry, height, weight and smoking history were collected prospectively and linked to individuals' primary care records. \"Treatable traits\" were identified from primary care records (frequent exacerbations, current smoking, low body mass index, respiratory failure, severe breathlessness, potential suitability for lung volume reduction or psychological comorbidity). Differences in demographics and health usage between those with and without \"treatable traits\" were assessed.</p><p><strong>Results: </strong>In total, of the 347 individuals with COPD, 186 had at least one \"treatable trait\". Compared to those without treatable traits, individuals with treatable traits were younger (61 vs 64 years, p<0.001), had more severe airflow obstruction (FEV<sub>1</sub> 86% vs 94% predicted, p=0.002), higher eosinophil count (0.32 vs 0.27 cells/μL, p=0.04) and were more socioeconomically deprived (UK Indices of Multiple Deprivation decile 4.3 vs 5.8, p<0.001). Individuals with treatable traits had a higher annual primary care health usage (47 vs 30 visits per year, p=0.001). Referrals rates to specialist respiratory services were low in both groups.</p><p><strong>Conclusion: </strong>Treatable traits are common in COPD and can be identified from routinely collected primary care data. Treatable traits are associated with younger age and greater deprivation. These individuals pose a significant burden to primary care yet are rarely referred to specialist respiratory services.</p>","PeriodicalId":48818,"journal":{"name":"International Journal of Chronic Obstructive Pulmonary Disease","volume":"20 ","pages":"2761-2766"},"PeriodicalIF":3.1000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335837/pdf/","citationCount":"0","resultStr":"{\"title\":\"Identifying Eligibility for Specialist Intervention in COPD from UK Primary Care Data: A \\\"Treatable Traits\\\" Approach.\",\"authors\":\"Thomas J C Ward, Catherine John, Alexander T Williams, Chiara Batini, Neil J Greening, Martin D Tobin, Michael C Steiner\",\"doi\":\"10.2147/COPD.S502865\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Specialist intervention in COPD is often reactive, resulting in inequalities in the provision of care. A proactive approach, in which individuals with modifiable disease are identified from primary care records, may help to tackle this inequality in access.</p><p><strong>Aim: </strong>To estimate the prevalence of \\\"treatable traits\\\" in COPD in a primary care research database and to assess health service usage.</p><p><strong>Methods: </strong>We performed a secondary analysis of individuals with either 1) a primary care diagnosis of COPD or 2) obstructive spirometry and history of ever smoking in a large observational study recruiting individuals aged 40-69 years old in Leicestershire, UK. Spirometry, height, weight and smoking history were collected prospectively and linked to individuals' primary care records. \\\"Treatable traits\\\" were identified from primary care records (frequent exacerbations, current smoking, low body mass index, respiratory failure, severe breathlessness, potential suitability for lung volume reduction or psychological comorbidity). Differences in demographics and health usage between those with and without \\\"treatable traits\\\" were assessed.</p><p><strong>Results: </strong>In total, of the 347 individuals with COPD, 186 had at least one \\\"treatable trait\\\". Compared to those without treatable traits, individuals with treatable traits were younger (61 vs 64 years, p<0.001), had more severe airflow obstruction (FEV<sub>1</sub> 86% vs 94% predicted, p=0.002), higher eosinophil count (0.32 vs 0.27 cells/μL, p=0.04) and were more socioeconomically deprived (UK Indices of Multiple Deprivation decile 4.3 vs 5.8, p<0.001). Individuals with treatable traits had a higher annual primary care health usage (47 vs 30 visits per year, p=0.001). Referrals rates to specialist respiratory services were low in both groups.</p><p><strong>Conclusion: </strong>Treatable traits are common in COPD and can be identified from routinely collected primary care data. Treatable traits are associated with younger age and greater deprivation. These individuals pose a significant burden to primary care yet are rarely referred to specialist respiratory services.</p>\",\"PeriodicalId\":48818,\"journal\":{\"name\":\"International Journal of Chronic Obstructive Pulmonary Disease\",\"volume\":\"20 \",\"pages\":\"2761-2766\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335837/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Chronic Obstructive Pulmonary Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/COPD.S502865\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/COPD.S502865","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

摘要

背景:慢性阻塞性肺病的专科干预往往是被动的,导致提供护理的不平等。积极主动的做法,即从初级保健记录中确定患有可改变疾病的个人,可能有助于解决这种获取不平等的问题。目的:在一个初级保健研究数据库中估计COPD中“可治疗特征”的流行程度,并评估卫生服务的使用情况。方法:我们在英国莱斯特郡进行了一项大型观察性研究,招募年龄在40-69岁之间的个体,对1)初级保健诊断为COPD或2)阻塞性肺活量测定和有吸烟史的个体进行了二次分析。前瞻性地收集肺活量、身高、体重和吸烟史,并将其与个人的初级保健记录联系起来。从初级保健记录中确定“可治疗的特征”(频繁恶化、目前吸烟、低体重指数、呼吸衰竭、严重呼吸困难、肺容量减少的潜在适宜性或心理合并症)。评估了具有和不具有“可治疗特征”的人群在人口统计学和健康使用方面的差异。结果:在347例COPD患者中,186例至少具有一种“可治疗特征”。与没有可治疗特征的患者相比,具有可治疗特征的患者更年轻(61岁vs 64岁,p1为86% vs 94%, p=0.002),嗜酸性粒细胞计数更高(0.32 vs 0.27细胞/μL, p=0.04),社会经济状况更差(英国多重剥夺指数十分位数4.3 vs 5.8, p)。结论:可治疗特征在COPD中很常见,可以从常规收集的初级保健数据中识别出来。可治疗的特征与更年轻和更严重的剥夺有关。这些人对初级保健造成重大负担,但很少被转介到专科呼吸服务。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Identifying Eligibility for Specialist Intervention in COPD from UK Primary Care Data: A "Treatable Traits" Approach.

Identifying Eligibility for Specialist Intervention in COPD from UK Primary Care Data: A "Treatable Traits" Approach.

Identifying Eligibility for Specialist Intervention in COPD from UK Primary Care Data: A "Treatable Traits" Approach.

Background: Specialist intervention in COPD is often reactive, resulting in inequalities in the provision of care. A proactive approach, in which individuals with modifiable disease are identified from primary care records, may help to tackle this inequality in access.

Aim: To estimate the prevalence of "treatable traits" in COPD in a primary care research database and to assess health service usage.

Methods: We performed a secondary analysis of individuals with either 1) a primary care diagnosis of COPD or 2) obstructive spirometry and history of ever smoking in a large observational study recruiting individuals aged 40-69 years old in Leicestershire, UK. Spirometry, height, weight and smoking history were collected prospectively and linked to individuals' primary care records. "Treatable traits" were identified from primary care records (frequent exacerbations, current smoking, low body mass index, respiratory failure, severe breathlessness, potential suitability for lung volume reduction or psychological comorbidity). Differences in demographics and health usage between those with and without "treatable traits" were assessed.

Results: In total, of the 347 individuals with COPD, 186 had at least one "treatable trait". Compared to those without treatable traits, individuals with treatable traits were younger (61 vs 64 years, p<0.001), had more severe airflow obstruction (FEV1 86% vs 94% predicted, p=0.002), higher eosinophil count (0.32 vs 0.27 cells/μL, p=0.04) and were more socioeconomically deprived (UK Indices of Multiple Deprivation decile 4.3 vs 5.8, p<0.001). Individuals with treatable traits had a higher annual primary care health usage (47 vs 30 visits per year, p=0.001). Referrals rates to specialist respiratory services were low in both groups.

Conclusion: Treatable traits are common in COPD and can be identified from routinely collected primary care data. Treatable traits are associated with younger age and greater deprivation. These individuals pose a significant burden to primary care yet are rarely referred to specialist respiratory services.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.80
自引率
10.70%
发文量
372
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信